Primecap Management CO Bristol Myers Squibb CO Transaction History

Primecap Management CO

$136 Billion
Q2 2024

A detailed history of Primecap Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Primecap Management CO holds 23,498,604 shares of BMY stock, worth $1.14 Billion. This represents 0.72% of its overall portfolio holdings.

Number of Shares

23,498,604

Previous 23,273,407 0.97%

Holding current value

$1.14 Billion

Previous $1.26 Billion 22.68%

% of portfolio

0.72%

Previous 0.96%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $9.06 Million - $11.9 Million	225,197 Added 0.97%	23,498,604 $976 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $12.5 Million - $14.2 Million	-260,971 Reduced 1.11%	23,273,407 $1.26 Billion
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $145 Million - $173 Million	2,998,228 Added 14.6%	23,534,378 $1.21 Billion
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $23.8 Million - $26.6 Million	-410,895 Reduced 1.96%	20,536,150 $1.19 Billion
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $36.1 Million - $40.1 Million	-567,360 Reduced 2.64%	20,947,045 $1.34 Billion
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $22.5 Million - $25.5 Million	-342,160 Reduced 1.57%	21,514,405 $1.49 Billion
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $19.3 Million - $22.8 Million	-281,110 Reduced 1.27%	21,856,565 $1.57 Billion
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $9,623 - $5.69 Million	-74,030 Reduced 0.33%	22,137,675 $1.57 Billion
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $11.5 Million - $12.7 Million	-158,670 Reduced 0.71%	22,211,705 $1.71 Billion
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $15.7 Million - $18.9 Million	255,920 Added 1.16%	22,370,375 $1.63 Billion
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $171 Million - $200 Million	3,195,680 Added 16.89%	22,114,455 $1.38 Billion
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $559,156 - $654,979	-9,450 Reduced 0.05%	18,918,775 $1.12 Billion
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $19.1 Million - $20.8 Million	-308,740 Reduced 1.6%	18,928,225 $1.26 Billion
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $18 Million - $20.3 Million	-303,483 Reduced 1.55%	19,236,965 $1.21 Billion
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $24.4 Million - $27.7 Million	-423,277 Reduced 2.12%	19,540,448 $1.21 Billion
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $37.9 Million - $42 Million	-660,070 Reduced 3.2%	19,963,725 $1.2 Billion
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $60.2 Million - $70.3 Million	-1,097,360 Reduced 5.05%	20,623,795 $1.21 Billion
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $51.1 Million - $74.2 Million	-1,100,700 Reduced 4.82%	21,721,155 $1.21 Billion
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $21 Million - $27.4 Million	426,180 Added 1.9%	22,821,855 $1.46 Billion
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $27 Million - $32.1 Million	632,340 Added 2.91%	22,395,675 $1.14 Billion
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $630,926 - $697,667	14,140 Added 0.07%	21,763,335 $987 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $143 Million - $171 Million	3,171,821 Added 17.07%	21,749,195 $1.04 Billion
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $16.1 Million - $20.8 Million	-329,320 Reduced 1.74%	18,577,374 $966 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $47.6 Million - $53.7 Million	862,900 Added 4.78%	18,906,694 $1.17 Billion
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $81.5 Million - $102 Million	1,612,844 Added 9.82%	18,043,794 $999 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $592 Million - $681 Million	9,873,372 Added 150.56%	16,430,950 $1.04 Billion
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $10.9 Million - $11.9 Million	182,678 Added 2.87%	6,557,578 $402 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $352 Million - $406 Million	6,374,900	6,374,900 $406 Million

Others Institutions Holding BMY

# of Institutions

2,399

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Bristol Myers Squibb CO Transaction History